BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2005
View Archived Issues
IoGen begins phase III trials
Read More
Duska acquires P2 receptor-based technology to treat glaucoma
Read More
Kalypsys and NovImmune form collaboration
Read More
Napo grants AsiaPharm license for crofelemer products in China
Read More
Good safety profile reported for new topical indomethacin in healthy subjects
Read More
First clinical data on the protective effects of FluBlOk against influenza
Read More
Update on the effects and safety of istradefylline in Parkinson's disease
Read More
Albumin therapy improves outcome after ischemic stroke
Read More
Pulsatile amoxicillin reported less effective than penicillin in strep throat
Read More
Novasite acquires PsyCheNomicS
Read More
New share issue to raise funds for alpha-HGA development at Tripep
Read More
BiDil recommended for heart failure in self-identified African Americans
Read More
Preclinical results for Senesco's Factor 5A siRNA
Read More
Teikoku Hormone accelerates new drug development
Read More
VALOR study of Talent thoracic stent graft system
Read More
SHP-1 identified as a negative modulator of insulin signaling and hepatic insulin clearance
Read More
CXCR3 ligands characterized in vitro using NBI-74330
Read More
ALK5 inhibitor effective in nephritis-induced renal fibrosis in rats
Read More
Sativex launched in Canada
Read More
Talactoferrin shows promise in the treatment of diabetic neuropathic ulcers
Read More
Clinical evidence supports the use of decitabine in MDS
Read More
Levemir receives FDA approval
Read More
Update on the effects and safety of tipifarnib in hematological malignancies
Read More
Exenatide reported effective as second-line therapy for type 2 diabetes
Read More
Recent patents describe novel antiinfective agents
Read More
New treatments claimed for lipoprotein disorders and obesity
Read More
New 5-HT receptor agonists for gastrointestinal disorders claimed by Pfizer
Read More